People
Filter News
Found 43,032 articles
-
According to the report, the majority of the cuts will occur in the company’s Human Health Division and are expected to begin Jan. 3 and conclude Jan. 16, 2020.
-
BioSpace Movers & Shakers, Oct. 18
10/18/2019
Pharma, biotech and medtech companies strengthen their executive ranks and boards with this week's Movers & Shakers. -
On Target Laboratories Appoints Vice President of Regulatory and Quality
10/18/2019
On Target Laboratories, Inc., a privately held biotechnology company that is developing tumor-targeted imaging agents to improve cancer surgery, announced today the appointment of Kimberly Fabrizio as Vice President of Regulatory and Quality.
-
LifeMine Therapeutics Powers Drug Discovery Team to Search the Biosphere for Nature's Evolved Solutions to Intractable Therapeutic Challenges
10/18/2019
LifeMine Therapeutics today announced several key appointments to its drug discovery team to include, Iain McFadyen, Ph.D., as Chief Data Officer; Jared Cumming, Ph.D., as Senior Vice President and Head of Chemistry; and Dawn Thomspon, Ph.D., as Vice President and Head of Microbiology and Automation
-
Generex Biotechnology Chief Medical & Scientific Officer Dr. Jason Terrell, MD is Awarded the 2019 Shepperd Pathfinder Award from the John Ben Shepperd Public Leadership InstituteDr. Terrell is recognized for his Work in the Fight Against Cancer
10/18/2019
Generex Biotechnology Corporation (OTCQB:GNBT) is pleased and proud to announce that the company’s Chief Medical and Scientific Officer Dr. Jason Terrell, MD was recently awarded the Shepperd Pathfinder Award for his work in cancer research.
-
Reenie McCarthy, chief executive officer of Stealth Biotherapeutics, has seen first-hand the negative impact of mitochondrial diseases, including watching an athlete decline from being an Olympic-level rower to becoming wheelchair-bound.
-
Netherlands-based Pharming Group NV has denied any involvement in a potential theft of intellectual property belonging to CSL Behring from Joseph Chiao, who recently joined Pharming as medical director.
-
HepaRegeniX GmbH Announces Management Changes
10/17/2019
HepaRegeniX GmbH, a preclinical stage company developing a novel therapy for the treatment of acute and chronic liver diseases announced the appointment of seasoned biotech expert Dr. Michael Lutz as new CEO and Managing Director of the company..
-
STALICLA Appoints Stéphane Baudouin as Chief of Science
10/17/2019
Neurobiologist with ten years’ Autism Spectrum Disorder experience takes on the lead research strategy role at the Swiss biotech
-
Medicom, Leader in Infection Control, Announces Recent Appointments and the Expansion of Portfolio of Innovative Infection Control Products
10/17/2019
AMD Medicom Inc. ("Medicom"), a leader in infection control and prevention products, is pleased to announce the appointment of Guillaume Laverdure to the position of President, North America, and Ouriel Levy to the position of Executive Vice President, Commercial.
-
Impel NeuroPharma Announces Appointment Of Diane Wilfong To Board Of Directors
10/17/2019
Impel NeuroPharma, a late-stage biopharmaceutical company focused on the development and commercialization of transformative therapies for patients living with central nervous system (CNS) disorders with high unmet medical needs, today announced that Diane Wilfong has been appointed to the Company's board of directors.
-
Clinical Laserthermia Systems Americas Names Michael Magnani as Managing DirectorIndustry Veteran to Lead Company in Next Stages of Growth and Commercialization for MRI-Guided, Precision Laser Ablation Systems and Accessories
10/17/2019
Clinical Laserthermia Systems Americas, Inc., a subsidiary of CLS AB in Lund, Sweden, announced that industry veteran Michael Magnani has joined the company as Managing Director for the U.S. and North American markets.
-
United Spinal Announces Six New Appointments To Its Board Of Directors
10/17/2019
United Spinal strives to build diverse perspectives and backgrounds within their board of directors so they can effectively address intersectional issues impacting people with disabilities and reach underserved populations
-
Arcadia Names Value-Based Care Leader as Chief Operating Officer
10/17/2019
Heather Trafton brings broad clinical, operational and technical expertise and additional hands-on healthcare management experience to Arcadia's leadership team
-
Senti Biosciences Announces Dr. Brenda Cooperstone as New Independent Board Member
10/17/2019
Leading gene circuit company recruits experienced drug developer for board of directors’ position to help steward clinical translation of gene circuit therapies
-
Can-Fite and Gebro Pharma holding European Conference on Development & Commercialization of Phase III Drug Candidate Piclidenoson in the Treatment of Rheumatoid Arthritis
10/17/2019
Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases and Gebro Pharma, a European mid-size Pharmaceutical company announced today it is holding an International Advisory Board conference with a panel of eleven Key Opinion Leaders in rheumatoid arthritis from Austria, Switzerland, and Spain focused on Piclidenoson.
-
Solos Endoscopy, Inc. Appoints Distributor to Expand Their MammoView Sales Into India
10/17/2019
This is a follow up to the successful introduction, by Shreyaas Healthcare, of Solos’ MammoView ductoscopy products at the 8th Annual Conference of Association of Breast Surgeons of India
-
Cadent Therapeutics Appoints Christopher Kenney, M.D. as Chief Medical Officer and Provides Clinical Update
10/17/2019
Cadent Therapeutics, a company focused on the development of therapies to improve the lives of patients with movement, mood, and cognitive disorders, announced the appointments of Christopher Kenney, M.D. as Chief Medical Officer and Dawn Wilson as Vice President of Clinical Operations
-
Dr. Kapil Moza Has Made The Prestigious Southern California Super Doctors List For The Fifth Consecutive Year
10/17/2019
According to the Super Doctor's Website, "In selecting physicians for Super Doctors, MSP Communications employs a rigorous multi-step process designed to identify physicians who have attained a high degree of peer recognition and professional achievement."
-
Inversago Pharma Strengthens its Board of Directors with the Appointment of Two Industry Experts
10/17/2019
Today Inversago Pharma Inc., a preclinical-stage biotech company developing novel CB1 blockers for the treatment of targeted metabolic disorders, announced the appointment of two seasoned pharma executives in line with the Company’s aim to attract first-class industry leaders for their guidance and expertise.